Literature DB >> 7252406

A new Fc receptor on mouse macrophages binding IgG3.

B Diamond, D E Yelton.   

Abstract

Monoclonal antibodies to sheep erythrocytes (SRBC) have proved useful in identifying two Fc receptors on mouse macrophages, one for IgG2a, and one for IgG1 and IgG2b. We have used monoclonal IgG3 anti-SRBC to identify a third Fc receptor on mouse macrophages which binds IgG3 uniquely. This receptor is present on primary resident and thioglycolate-induced peritoneal macrophages and on some macrophage cell lines. The binding of IgG3-coated SRBC is inhibited by aggregated byt not monomeric IgG3, and not by IgG1, IgG2a, and IgG2b aggregates. It is unaffected by treating the macrophages with trypsin or cytochalasin B and occurs at both 4 degrees and 37 degrees C. IgG3, like all other IgG subclasses, mediates phagocytosis. We have also generated a variant macrophage line which bears the receptors for IgG1 and IgG2b and for IgG2a, but not for IgG3.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7252406      PMCID: PMC2186114          DOI: 10.1084/jem.153.3.514

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  20 in total

1.  Different roles of IgG and complement receptors in phagocytosis by polymorphonuclear leukocytes.

Authors:  B Mantovani
Journal:  J Immunol       Date:  1975-07       Impact factor: 5.422

2.  Separate Fc-receptors for immunoglogulins IgG2a and IgG2b on an established cell line of mouse macrophages.

Authors:  W S Walker
Journal:  J Immunol       Date:  1976-04       Impact factor: 5.422

3.  Antiphagocytic effects of staphylococcal protein A.

Authors:  J H Dossett; G Kronvall; R C Williams; P G Quie
Journal:  J Immunol       Date:  1969-12       Impact factor: 5.422

4.  Growth of primary plasmacytomas in the mineral oil-conditioned peritoneal environment.

Authors:  M Potter; J G Pumphrey; J L Walters
Journal:  J Natl Cancer Inst       Date:  1972-07       Impact factor: 13.506

5.  Suppression and augmentation of the primary in vitro immune response by different classes of antibodies.

Authors:  J Gordon; R A Murgita
Journal:  Cell Immunol       Date:  1975-02       Impact factor: 4.868

6.  Protein A reactivity with mouse immunoglobulins. Structural relationship between some mouse and human immunoglobulins.

Authors:  G Kronvall; H M Grey; R C Williams
Journal:  J Immunol       Date:  1970-11       Impact factor: 5.422

7.  Neutrophil receptors for IgG and complement: their roles in the attachment and ingestion phases of phagocytosis.

Authors:  D J Scribner; D Fahrney
Journal:  J Immunol       Date:  1976-04       Impact factor: 5.422

8.  Reticulum cell sarcoma: an effector cell in antibody-dependent cell-mediated immunity.

Authors:  P Ralph; J Prichard; M Cohn
Journal:  J Immunol       Date:  1975-02       Impact factor: 5.422

9.  Studies of the macrophage complement receptor. Alteration of receptor function upon macrophage activation.

Authors:  C Bianco; F M Griffin; S C Silverstein
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

10.  A new mouse immunoglobulin: IgG3.

Authors:  H M Grey; J W Hirst; M Cohn
Journal:  J Exp Med       Date:  1971-02-01       Impact factor: 14.307

View more
  38 in total

1.  Immunoglobulin G3 antibodies specific for the 19-kilodalton carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein 1 transfer protection to mice deficient in Fc-gammaRI receptors.

Authors:  P Vukovic; P M Hogarth; N Barnes; D C Kaslow; M F Good
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

Review 2.  Isotype-dependent pathogenicity of autoantibodies: analysis in experimental autoimmune hemolytic anemia.

Authors:  S Izui; L Fossati-Jimack; S A da Silveira; T Moll
Journal:  Springer Semin Immunopathol       Date:  2001-12

Review 3.  An experimental model of cryoglobulin-associated vasculitis in mice.

Authors:  Y Pastore; F Lajaunias; A Kuroki; T Moll; S Kikuchi; S Izui
Journal:  Springer Semin Immunopathol       Date:  2001

4.  Human immunoglobulin G2 (IgG2) and IgG4, but not IgG1 or IgG3, protect mice against Cryptococcus neoformans infection.

Authors:  David O Beenhouwer; Esther M Yoo; Chun-Wei Lai; Miguel A Rocha; Sherie L Morrison
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

5.  Integrin β1 Promotes the Interaction of Murine IgG3 with Effector Cells.

Authors:  Carolyn Saylor Hawk; Carolina Coelho; Diane Sthefany Lima de Oliveira; Verenice Paredes; Patrícia Albuquerque; Anamélia Lorenzetti Bocca; Ananésia Correa Dos Santos; Victoria Rusakova; Heather Holemon; Ildinete Silva-Pereira; Maria Sueli Soares Felipe; Hideo Yagita; André Moraes Nicola; Arturo Casadevall
Journal:  J Immunol       Date:  2019-03-20       Impact factor: 5.422

6.  Characterization of the Fc(IgG) receptor on the pluripotential leukaemia cell K-562.

Authors:  A T Ichiki; C J Wust; C B Lozzio
Journal:  Clin Exp Immunol       Date:  1985-01       Impact factor: 4.330

7.  Genetic analysis of the role of cAMP in mediating effects of interferon.

Authors:  J Schneck; B Rager-Zisman; O M Rosen; B R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

8.  Dynamics of actin filaments in microglia during Fc receptor-mediated phagocytosis.

Authors:  E M Abd-el-Basset; S Fedoroff
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

9.  Murine IgG1 and IgG3 isotype switch variants promote phagocytosis of Cryptococcus neoformans through different receptors.

Authors:  Carolyn A Saylor; Ekaterina Dadachova; Arturo Casadevall
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

10.  Binding of mouse monoclonal antibodies to human leukaemic cells via the Fc receptor: a possible source of 'false positive' reactions in specificity screening.

Authors:  S J Gadd; L K Ashman
Journal:  Clin Exp Immunol       Date:  1983-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.